CHEMBL1380345

CAS No. 793713-92-5

CHEMBL1380345( N,N'-(Ethane-1,2-diyl)bis(3-methylbenzenesulfonamide) )

Catalog No. M28539 CAS No. 793713-92-5

CHEMBL1380345 exhibits antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli with pMIC values of 3.64, 3.56, and 3.70, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CHEMBL1380345
  • Note
    Research use only, not for human use.
  • Brief Description
    CHEMBL1380345 exhibits antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli with pMIC values of 3.64, 3.56, and 3.70, respectively.
  • Description
    CHEMBL1380345 exhibits antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli with pMIC values of 3.64, 3.56, and 3.70, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N,N'-(Ethane-1,2-diyl)bis(3-methylbenzenesulfonamide)
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    793713-92-5
  • Formula Weight
    368.47
  • Molecular Formula
    C16H20N2O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(=O)(NCCNS(=O)(=O)C=1C=CC=C(C1)C)C=2C=CC=C(C2)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Minocycline hydrochl...

    A tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects.

  • Clonixin

    Clonixin is a non-steroidal anti-inflammatory drug (NSAID) with analgesic properties.

  • Capreomycin sulfate

    A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.